Alterity Therapeutics ATHE
NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Capital Expenditures (2016 - 2018)

Updated

Alterity Therapeutics (ATHE) posted Capital Expenditures of -$5,722 for the year ended Aug 29, 2024.

Analysis

Alterity Therapeutics (ATHE) Capital Expenditures (2016 - 2018) Analysis & Trends

Since the year ended Jun 30, 2009, Alterity Therapeutics has reported Capital Expenditures for 13 years.

  • Annual Capital Expenditures has run from a low of -$11,305 in the year ended Aug 31, 2020 to a high of $63,853 in the year ended Jun 30, 2022 over five years.
  • Business Quant data shows ATHE's Capital Expenditures at -$7,311 in the year ended Dec 31, 2023, $63,853 in the year ended Jun 30, 2022 (+691.8%), $8,064 in the year ended Jun 30, 2021 and -$11,305 in the year ended Aug 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Alterity Therapeutics 41.90 Mn -41.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -2,348.04
Dec 31, 2017 -2,567.05
Dec 31, 2016 -16,622.76
API Access

Alterity Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ATHE&period=max&api_key=YOUR_API_KEY